ABSTRACT 25 studies involving 755 hips in 534 patients were reviewed to determine the complication rates of total hip replacement in haemodialysis or renal transplant patients. In comparison of both groups, renal transplant patients were generally younger and more likely to receive an uncemented implant, whereas haemodialysis patients had approximately twice the infection rate and higher rates of mortality, revision, aseptic loosening, and hip dislocation. Both groups had increased complication rates, compared with patients without renal failure.
indication for THR. 1 Joint degeneration secondary to renal disease is also a common indication. The need for THR in patients with end-stage renal disease or post-renal transplant is multifactorial. Long-term haemodialysis patients develop renal osteodystrophy and β2-microglobulin amyloid deposition in and around joints. 4, 5 They have a relative risk of needing a THR of 6.6, compared with the general population. 6 Renal transplant patients receive life-long immunosuppressive therapy, including corticosteroids, and thus are at increased risk of avascular necrosis (AVN) of the femoral head. The incidence of AVN among renal transplant patients is 4.5%. 7, 8 Histological evidence of abnormal bone structure (osteodystrophy and osteopenia) is present soon after transplantation in almost all patients. 9 This is due to post-transplantation medical therapy and pre-existing damage from pre-transplant dialysis. The number of patients undergoing long-term renal dialysis or with renal transplant is increasing, 10, 11 as is the number of these patients undergoing THR. 12 THR improves pain and function in patients with end-stage renal disease or post-renal transplant. 11, 13 In patients without renal disease, the 30-and 90-day mortality rates are 0.24% and 0.55%, respectively, 14 and the deep infection rate, revision rate at 10 years, and dislocation rate are <1.1%, <7.5%, and <5.0%, respectively. [15] [16] [17] In renal transplant patients, cemented THR provides good-to-excellent functional outcomes, despite increased complication rates. 18 We aimed to review the rates and types of complications in haemodialysis or renal transplant patients after THR.
MATERIALS AND METHODS
English-language articles published before April 2013 in the EMBASE and MEDLINE were searched using the key words: hip arthroplasty, prosthesis, joint, renal dialysis, kidney failure, and renal replacement therapy. 25 studies involving 755 THRs in 534 patients who were undergoing haemodialysis or had had a renal transplant and then underwent primary THR were reviewed. 11, 13, Of the studies, 9 included haemodialysis patients only, 11, [19] [20] [21] [22] 36, 37, 39, 40 11 included renal transplant patients only, [23] [24] [25] [26] [27] 28, [31] [32] [33] 38, 41 and 5 included both. 13, 29, 30, 34, 35 According to the quality assessment for case series questionnaire of the National Institute for Health and Care Excellence (Table 1) , the mean score for study quality was 3. Table 2 ). The mean follow-up was 99 months (range, 1 month to 18 years). The time from transplant to THR ranged from 0 to 14.5 years. The causes of renal impairment varied. The indication for THR included AVN (n=582), fracture (n=3), osteoarthritis (n=5), amyloidosis (n=4), chondrocalcinosis (n=2), and unknown (n=6). THRs were cemented (n=469), uncemented (n=61), hybrid (n=19), and unknown (n=53). The mean Harris Hip score improved from 32.4 to 89.1 in 8 studies. 13, [23] [24] [25] 30, 32, 33, 41 Respectively in the haemodialysis and renal transplant groups, all-cause mortality rates at one year were 6.3% (n=8) and 4.4% (n=18), and during the study periods were 33.6% (n=43) and 25.4% (n=103) [ Table 3 ]. Only 7 deaths in each group were attributable to the surgical procedure; almost all were due to sepsis secondary to deep infection.
Respectively in the haemodialysis and renal transplant groups, revision rates at one year were 2.6% (n=4) and 1.7% (n=10), and during the study periods were 16.3% (n=25) and 15.9% (n=96) [ Table  3 ]. In the haemodialysis group, 4 patients had early revisions: 3 were due to deep infection and underwent a Girdlestone procedure (n=2) or a 2-stage revision (n=1), and one was due to loosening of the cemented acetabular component on day 1 and underwent recementing during the same admission. For the remaining 21 revisions, the causes were deep infection (n=6), aseptic loosening (n=13), recurrent dislocation and aseptic loosening (n=1), and THR being 'never good' (n=1). In the renal transplant group, the 10 early revisions were due to deep infections (3 within 6 weeks) [n=5], aseptic loosening (n=3), and recurrent dislocation (n=2). 
Table 3 Complication rates after total hip replacement (THR) in haemodialysis and renal transplant patients
Respectively in the haemodialysis and renal transplant groups, the deep infection rates at one year were 2.6% (n=4) and 1.8% (n=11), and during the study periods were 8.5% (n=13) and 4.5% (n=27) [ Table 3 ]. In the haemodialysis group, one patient had methicillin-sensitive Staphylococcus aureus infection at 3 weeks and was successfully treated with debridement and intravenous antibiotics. One patient underwent revision arthroplasty and 2 others underwent resection arthroplasty. In the renal transplant group, one patient was treated with debridement only, 2 with resection arthroplasty, 2 progressed to septic loosening and underwent revision, and 5 died from complications of infection.
Respectively in the haemodialysis and renal transplant groups, the aseptic loosening rates were 17% (n=26) and 16.3% (n=98) [ Table 3 ]. In the haemodialysis group, 41 implant components (femoral or acetabular or both) were loosened: 20 were cemented, 3 were uncemented, and 18 were unknown. In the renal transplant group, 101 implant components (femoral or acetabular or both) were loosened: 72 were cemented, 2 were uncemented, and 27 were unknown. 66 of the patients underwent revision surgery.
Respectively in the haemodialysis and renal transplant groups, dislocation rates were 6.5% (n=10) and 6.0% (n=36) [ Table 3 ].
discussion
Patients with renal failure can tolerate surgery well, 42 but those with chronic renal failure have increased complication rates after cardiac, breast, abdominal, and colorectal surgeries. 43 In a meta-analysis of various non-cardiac surgeries, patients with chronic renal disease are at 2-to 5-fold higher risk for postoperative death and cardiovascular events than those with normal renal function. 44 Postoperative morbidity after elective orthopaedic surgery is also higher in patients with chronic renal disease. 45 According to the Australian Orthopaedic Association National Joint Replacement Registry, 1 the most common indication for primary THR is osteoarthritis (88.3%), followed by AVN (3.7%), femoral neck fracture (3.6%), rheumatoid arthritis (1.3%), and developmental dysplasia (1.3%). In contrast, in renal transplant patients, AVN is the most common indication, with an incidence of 5% after renal transplantation (owing to the use of immunosuppressants). 46 The incidence of AVN or amyloid-related arthropathy is also increased in haemodialysis patients. 47 According to the Australian Registry, 1 the mean patient age for conventional THR was 67 years in 2011. In our review of haemodialysis and renal transplant patients, the mean ages were 56 and 38 years, respectively. Haemodialysis patients usually have a mean of 6 to 18.8 years of dialysis before THR. 11, [19] [20] [21] [22] Renal transplant patients usually undergo THR after a mean of 2.5 to 5 years post-renal transplantation. [23] [24] [25] [26] [27] Renal transplant patients are generally younger and healthier than haemodialysis patients. 12 In standard THR, the early mortality rate is ≤0.55%.
14 In our review of haemodialysis and renal transplant patients, the one-year mortality rates were 6.3% and 4.4%, respectively. In one study, the respective one-year mortality rates were 16.1% (6.3% for patients awaiting renal transplant) and 3.8%. 12 In the Danish Hip Arthroplasty Registry, the post-THR mortality was lower in the general population than in age-matched patients. 48 Mortality rates were similar among the entire spectrum of renal transplant patients. 23 The mean time to death was roughly 50% longer for renal transplant than haemodialysis patients (39 vs. 63 months), probably indicating that haemodialysis patients are generally more frail. 23 In standard THR, the 5-year deep infection rates range from 0.2 to 1.1%. 15 In our review of haemodialysis and renal transplant patients, the deep infection rates were 8.5% and 4.5%, respectively. Although renal transplant patients are more likely to receive immunosuppressants, infection is twice as common in haemodialysis patients who are generally older and have more comorbidities. 12 In haemodialysis and renal transplant patients, deep infections were more likely to lead to death or resection arthroplasty rather than to component revision. Late infection is a major problem in renal transplant patients, with an incidence of 13%. 28 The use of prophylactic antibiotics is recommended whenever there is a risk of haematogenous seeding from transient bacteraemia. 28 In renal transplant patients after THR, rates of infection, thromboembolic events, dislocation, and loosening are increased, as is the mortality rate, but this is caused by comorbidities rather than the THR. 18 According to the National Institute for Health and Care Excellence, the revision rate for THR at 10 years should be <10% in the general population. The revision rate in renal transplant patients was 2 to 3 times higher, exceeding the thresholds deemed acceptable. According to the Australian Registry, a revision rate of >7.5% at 10 years is considered higher than anticipated. 1 Furthermore, many loose implants are not revised owing to the poor general condition or bone stock of the patients. Many haemodialysis and renal transplant patients died before revision or were not fit for revision surgery. 21, [29] [30] [31] [32] [33] The numbers of loosened femoral versus acetabular components were roughly equal, suggesting inadequate biological fixation.
In standard THR, the dislocation rate is around 2.2%. 49 In our review of haemodialysis and renal transplant patients, the dislocation rates were 6.5% and 6.0%, respectively. Dislocation is associated with aseptic loosening, 11 septic joints, 34, 35 seizure, 36 and early occurrence (within 30 days). 23, 27 THR remains a valid option for haemodialysis and renal transplant patients, despite having higher complication rates. In 5 studies comparing renal transplant versus haemodialysis patients, 13, 29, 30, 34, 35 all but one 30 reported good overall results with improvement in pain and function. Cemented fixation is recommended for haemodialysis patients, whereas cementless fixation is appropriate for renal transplant patients. 13 Special care of such patients must be taken. 29 One study reported a complication rate of 35% and did not recommend THR for haemodialysis patients. 21 Although uncemented THR has achieved promising results in recent years, 19, 20, 37 it is recommended that renal transplantation be performed before THR for those eligible. 36 In 11 studies of renal transplant patients, all concluded that THR was a good option. 13, [23] [24] [25] [26] [30] [31] [32] [33] [34] 41 Results for THR in renal transplant patients were comparable to those in general patients. 24, 33 THR is safe and effective for such patients and should be performed early. 33 Nonetheless, cemented THR is just the optimal option for such patients at present, 27 as survivorship of cemented THR decreases after 10 years, although survivorship at 10 years was similar to the general population. 31 The main limitation of this review was the difficulty of comparing and combining the results across different studies. Only 2 studies were conducted in multiple centres. 19, 30 Only 4 studies collected data prospectively, 11, 21, 34, 40 and only half of the studies clearly defined the outcome measures and sufficiently stratified the results to enable comparisons.
conclusion
Haemodialysis and renal transplant patients have increased risks of early and late complications after THR, especially haemodialysis patients. Nonetheless, both cemented and cementless THR can achieve good results in these patients.
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